Description
Conference RESERVED for healthcare professionals at Stillview Clinic ONLY.
Learning Objectives
PLACES ARE LIMITED TO 20 PARTICIPANTS.
At the end of the program, participants will be able to:
1. Assess antihyperglycemic therapy selection in patients with diabetes based on the Diabetes Canada Clinical Practice Guidelines;
2. Examine individualized therapy based on the patient’s A1C level, weight, and underlying cardiorenal risks;
3. Explore practical considerations for prescribing antihyperglycemic therapies based on safety, dosing, titration, administration, and patient priorities.
Speakers
Moderator : Dr. Naveen Garg. Conference given by Dr. Alexandro Zarruk.
Schedule
From 12:00 pm to 1:15 pm, Conference
Registration
It is important to register online in order to participate.
To cancel your registration, please contact Mrs. Aline Sabbagh at asabbagh@amom.net.
The AMOM recommends that all participants follow the provincial health guidelines related to the COVID-19 pandemic. Participants acknowledge and accept the health risks that may be associated with in-person participation and understand that they are solely responsible for assessing their own health and taking appropriate safety measures for their situation.
Conference Venue
This conference will be held at the Stillview Mes Soins Telus Santé Clinic.
Consent
An attendance list can be sent to the pharmaceutical company after the activity, if requested. By this registration, the general practitioner and/or any other healthcare professional consents to the disclosure of his first and last name to the pharmaceutical company.
The pharmaceutical company agrees not to communicate this information without the consent of the participant.
If you do not want your first and last name disclosed, please contact Ms. Aline Sabbagh at asabbagh@amom.net indicating the activity number.
Recognition of Educational Activities
L’Association des médecins omnipraticiens de Montréal, under the aegis of the FMOQ, recognizes 1.25 hours of professional development activity, of category 1, as required by the professional development regulations of the CMQ. The FMOQ number to retrieve your certificate is 84719.
Educational Subsidy
This activity has received an educational subsidy from Novo Nordisk Canada Inc.